Apatinib: A Novel Antiangiogenic Drug in Monotherapy or Combination Immunotherapy for Digestive System Malignancies

Overview of attention for article published in Frontiers in immunology, June 2022

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 8 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 34,251 followers.

New article: Apatinib: A Novel Antiangiogenic Drug in Monotherapy or Combination Immunotherapy for Digestive System Malignancies https://t.co/6ik1FdCz4B #livercancer #oncology https://t.co/4O02tvVxdA

18 Jul 2022

Reply Repost Favourite

New Research: Apatinib: A Novel Antiangiogenic Drug in Monotherapy or Combination Immunotherapy for Digestive System Malignancies: Digestive system malignancies are one of the primary causes of cancer-related death. Meanwhile, angiogenesis… https://t.co/o9

29 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.